Demand for Ozempic and Wegovy will soar in New Year - as people keen to lose weight say they'll enjoy one final festive feast before starting obesity drugs
Share:
Tis the season to make merry, indulge in seasonal boozing and ditch the diet on Christmas Day in favour of a slap-up turkey lunch - and then go on a diet come January 1st. The rise of Ozempic, Mounjaro and Wegovy into the mainstream in recent months means that the traditional post-Christmas purge might look a little different for many people this year.
As the most lucrative day in the diet industry looms, sales of such anti-obesity drugs are predicted to soar in the New Year - as those who've wanted one final festive blow-out decide to begin their weight-loss jab journey in earnest. A prescription for Wegovy in the UK is roughly the same price as an expensive gym's membership fees - from around £160 a month.
Famous users in the public eye such as Robbie Williams, Sharon Osbourne and Oprah Winfrey - who've all shown off dramatic results - has fuelled even more interest. On X this week, one person frustrated with their weight said the new year would mark a new beginning, writing: 'After the holidays, I’m buying Ozempic. Enough is enough.'.
Dry Jab-uary? Semiglutide weight-loss drugs such Ozempic and Wegovy went mainstream in 2024 - and January 2025 could see the anti-obesity drug manufacturers get a huge spike in sales. . New Year's resolution could give the weight-loss drug industry a shot in the arm, as people decide to pay for drugs such as Wegovy and Ozempic after a Christmas food and booze blow-out.